Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Sponsor
Allergan (Industry)
Overall Status
Completed
CT.gov ID
NCT00025818
Collaborator
(none)
290
17
22
17.1
0.8

Study Details

Study Description

Brief Summary

A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.

Condition or Disease Intervention/Treatment Phase
  • Drug: Ophthalmic Emulsion
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
290 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Study Start Date :
May 1, 2001
Actual Primary Completion Date :
Mar 1, 2003
Actual Study Completion Date :
Mar 1, 2003

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • Eighteen years or older

    • Diagnosis of moderate to severe dry eyes for at least 6 months and meet one or all of the following criteria:

    • Diagnosis of autoimmune disorder

    • Female 65 years of age or older

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Eyecare of La Jolla La Jolla California United States 92037
    2 UCLA Los Angeles California United States 90095
    3 Opticare Waterbury Connecticut United States 06708
    4 Brandon Eye Clinic Tampa Florida United States 33629
    5 Emory University Atlanta Georgia United States 30322
    6 UIC Eye Center Chicago Illinois United States 60612
    7 Indiana University Indianapolis Indiana United States 46202
    8 Hunkleler Eye Center Overland Park Kansas United States 66211
    9 D'Ambrosio Eye Care Leominster Massachusetts United States 01453
    10 Great Lakes Eye Institute Saginaw Michigan United States 48604
    11 Cornea Consultants of Albany Albany New York United States 12159
    12 Dr. Freedman's Office Brooklyn New York United States 11201
    13 Dr. Wittpen's Office Stony Brook New York United States 11790
    14 The Cole Eye Institute Cleveland Ohio United States 44195
    15 Northwest Cornea Portland Oregon United States 97223
    16 Corona Research El Paso Texas United States 79903
    17 Baylor College of Medicine Houston Texas United States 77030

    Sponsors and Collaborators

    • Allergan

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00025818
    Other Study ID Numbers:
    • 192371-011-01
    First Posted:
    Oct 29, 2001
    Last Update Posted:
    May 30, 2011
    Last Verified:
    May 1, 2011

    Study Results

    No Results Posted as of May 30, 2011